Versa Vascular
Versa Vascular is a developer of an implant system designed to treat tricuspid regurgitation by supporting native valve function.
$27.3M Series B+ ·
Led by Santa Cruz Ventures · Source: massdevice.com
Latest round on record: Series B+, August 2026, amount undisclosed.
All 3 rounds ↓Signals
Versa Vascular | 470 days on the record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
- Series B+ · amount undisclosedSource: fundraisingfox.com
- Series B+ · amount undisclosedSource: fundraisingfox.com
- Series B+ · $27.3M
SSanta Cruz Ventures (lead)
Source: massdevice.com - Website created
Founders and team
DW
Dan Wallace FounderBS
Bill Shields Chief Executive Officer
Investors
Companies like Versa Vascular
PPolares Medical$50M Series B+ · Mar 2026
QQV BioelectronicsSeries A · Jan 2023
VVandria$30.7M Series A · Aug 2024
CCheribundi$10M · Dec 2025
PPivot$40M Series B+ · May 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/versa-vascular (get a free API key).